Amryt Pharma
Michael Inglis has an extensive work history in the pharmaceutical industry. Michael is currently the Head of Manufacturing Sciences, Analytical Technologies at Chiesi Group, where they lead and develops technical teams in various modalities. Prior to that, they held positions at Amryt Pharma, Pfizer, Ipsen, Trinity Biotech, and Elan Pharmaceuticals, where they gained experience in manufacturing sciences, analytical technology, and production chemistry. Overall, their work experience spans over two decades, showcasing their expertise and knowledge in the industry.
Michael Inglis earned a Bachelor of Science degree in Bioanalytical Science from IT Tallaght in 1999. Michael later pursued a Master of Engineering Science degree in Biopharmaceutical Engineering at University College Dublin from 2007 to 2009.
This person is not in any offices
Amryt Pharma
Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases.